PI3K-alpha inhibitors (Exelixis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePI3K-alpha inhibitors (Exelixis)
Drug Alias NameEXEL-2054EXEL-8188EXEL-1370EXEL-3087EXEL-5080 +[6] 
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExelixis Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A